Crossmark

Does Prolonged Infusion Time Really Improve the Efficacy of Meropenem Therapy? A Prospective Study in Critically Ill Patients

Published Online: 2021-11-06

Published Print: 2022-02

Authors

Zhao, Yi-Chang

Zou, Yang

Xiao, Yi-Wen

Wang, Feng

Zhang, Bi-Kui

Xiang, Da-Xiong

Yu, Feng

Luo, Hong

Sandaradura, Indy

Yan, Miao https://orcid.org/0000-0002-3582-8305
Clinical Trials ^BETA

Clinical trials referenced in this document:

chictr1900020672 at Chinese Clinical Trial Registry

Documents that mention this clinical trial

Does Prolonged Infusion Time Really Improve the Efficacy of Meropenem Therapy? A Prospective Study in Critically Ill Patients
https://doi.org/10.1007/s40121-021-00551-2
Funding

Funding for this research was provided by:

hunan pharmaceutical association of china ([HMA202001002])
License Information

Text and Data Mining valid from 2021-11-06

Version of Record valid from 2021-11-06
More Information

Article History

Received: 25 June 2021

Accepted: 13 October 2021

First Online: 6 November 2021

Document is current